Lindbrook Capital, LLC - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$2,426
+21.3%
900.0%0.00%
Q3 2022$2,000
+100.0%
900.0%0.00%
Q2 2022$1,000
-50.0%
90
-35.7%
0.00%
Q1 2022$2,000
+100.0%
140
+55.6%
0.00%
Q4 2021$1,000
-95.7%
90
-91.0%
0.00%
-100.0%
Q2 2021$23,000
+9.5%
1,0000.0%0.01%0.0%
Q1 2021$21,000
-25.0%
1,0000.0%0.01%
-28.6%
Q4 2020$28,000
-60.0%
1,000
-80.0%
0.01%
-63.2%
Q3 2020$70,000
+600.0%
5,000
+900.0%
0.02%
+533.3%
Q2 2020$10,0005000.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 85,000$1,132,0001.20%
Bellevue Group AG 5,859,039$78,042,0000.91%
APIS CAPITAL ADVISORS, LLC 40,000$533,0000.64%
Pier Capital, LLC 294,954$3,929,0000.50%
Resolute Capital Asset Partners LLC 50,000$666,0000.42%
Rhenman & Partners Asset Management AB 249,300$3,321,0000.33%
Hennion & Walsh Asset Management, Inc. 409,079$5,449,0000.29%
TORRAY INVESTMENT PARTNERS LLC 79,868$1,064,0000.17%
PLATINUM INVESTMENT MANAGEMENT LTD 195,211$2,600,0000.08%
DUALITY ADVISERS, LP 54,164$721,0000.08%
View complete list of MYOVANT SCIENCES LTD shareholders